http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-100494833-B1
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2015-8572 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A01K2267-0331 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A01K2227-105 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-76 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-8509 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A01K67-0275 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-85 |
| filingDate | 2002-11-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2005-06-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2005-06-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-100494833-B1 |
| titleOfInvention | Transgenic mice inducing hepatocellular carcinoma by the expression of mutant type H-ras cDNA |
| abstract | The present invention relates to liver cancer expressing transgenic mice, and more particularly, H-ras overexpressed by introducing a H-ras gene in which the 12th codon is substituted with glycine to valine to produce liver cancer expressing transgenic mice. As liver cancer is expressed, the present invention relates to a liver cancer-expressing transgenic mouse that can be very useful for animal experiments when developing new drugs, as well as for the study of the pathogenesis of liver cancer and the discovery of new genes involved in the development of liver cancer. |
| priorityDate | 2002-11-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 253.